Unncanny Biotech Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 30-12-2024
- Paid Up Capital ₹ 0.10 M
as on 30-12-2024
- Company Age 6 Year, 4 Months
About Unncanny Biotech
The Company is engaged in the Pharma Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Atul Patil, Amol Jadhav, Hasan Aga, and One other member serve as directors at the Company.
- CIN/LLPIN
U33119MH2018PTC313193
- Company No.
313193
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Aug 2018
- Date of AGM
-
- Date of Balance Sheet
-
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Unncanny Biotech Private Limited offer?
Unncanny Biotech Private Limited offers a wide range of products and services, including TB, Tumor & Cancer Drugs, Anti Cancer Injection, Industrial Uniforms & Safety Wear, Rubber Gloves, Nutraceuticals & Dietary Supplements, Nutritional Supplements, Animal Medicines & Health Care, Veterinary Vaccines, Anti Infective Drugs & Medicines, Antibiotic Injection.
Who are the key members and board of directors at Unncanny Biotech?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Atul Patil  | Director | 29-Aug-2018 | Current |
| Amol Jadhav | Director | 29-Aug-2018 | Current |
| Hasan Aga | Director | 16-Sep-2022 | Current |
| Shankarrao Jadhav | Director | 16-Sep-2022 | Current |
Financial Performance of Unncanny Biotech.
Enhance accessibility to Unncanny Biotech's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Unncanny Biotech?
Unlock access to Unncanny Biotech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Krushikisan Agri Power & Sugar Industries LimitedActive 11 years 5 monthsAtul Patil is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Unncanny Biotech?
Unlock and access historical data on people associated with Unncanny Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Unncanny Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Unncanny Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
